Replies to post #32803 on PharmaCyte Biotech Inc (PMCB)

[Deborah1]

Here's the link...

http://www.otcjournal.com/FDA-Trials-Close-At-Hand-For-Pharmacyte-PMCB/af/archive/20150129-1/

[Peacefulwendy]

Here is a video clip of Dr Von Hoff. Truly an amazing man.. We are blessed that he was intersted in Cell in a Box(R) technology. And we are hopeful the blessing will be passed on to others in need.

"The Nuvilex team presents us with a new tool to employ against the symptoms and invasive properties of this very challenging cancer," said Daniel D. Von Hoff, M.D., Chief Development Officer of TD2. "Our Pancreatic Cancer Research Team (PCRT) colleagues are enthusiastic to begin clinical trials with this approach."

http://www.td2inc.com/news/nuvilex-selects-translational-drug-development-td2-to-advanc

[HighHoeSilverado]

Again. I no get it. So he works for the company that's doing the studies. Wow!!!! That's his job. IMHO von Hoff will never promote a high risk company like this. Td2 will be the only 1 that technically can say anything.